Schaper Benz & Wise Investment Counsel Inc. WI grew its position in shares of Veeva Systems Inc. (NYSE:VEEV - Free Report) by 31.0% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 5,921 shares of the technology company's stock after acquiring an additional 1,402 shares during the quarter. Schaper Benz & Wise Investment Counsel Inc. WI's holdings in Veeva Systems were worth $1,245,000 at the end of the most recent quarter.
Other large investors also recently modified their holdings of the company. Amundi grew its stake in Veeva Systems by 9.8% during the fourth quarter. Amundi now owns 459,044 shares of the technology company's stock worth $99,750,000 after buying an additional 40,884 shares during the period. Larson Financial Group LLC raised its position in Veeva Systems by 8.2% in the fourth quarter. Larson Financial Group LLC now owns 1,736 shares of the technology company's stock valued at $365,000 after purchasing an additional 132 shares during the period. Bank Julius Baer & Co. Ltd Zurich lifted its stake in shares of Veeva Systems by 1.6% during the fourth quarter. Bank Julius Baer & Co. Ltd Zurich now owns 79,771 shares of the technology company's stock worth $17,919,000 after purchasing an additional 1,294 shares in the last quarter. EFG Asset Management Americas Corp. boosted its position in shares of Veeva Systems by 4.2% in the fourth quarter. EFG Asset Management Americas Corp. now owns 17,236 shares of the technology company's stock worth $3,624,000 after buying an additional 687 shares during the period. Finally, BBR Partners LLC acquired a new stake in shares of Veeva Systems in the fourth quarter valued at about $282,000. 88.20% of the stock is currently owned by hedge funds and other institutional investors.
Analyst Ratings Changes
A number of equities analysts have weighed in on VEEV shares. Mizuho started coverage on Veeva Systems in a report on Wednesday, December 4th. They issued an "outperform" rating and a $275.00 price target for the company. Piper Sandler raised their price target on shares of Veeva Systems from $280.00 to $290.00 and gave the company an "overweight" rating in a report on Friday, December 6th. Citigroup boosted their price objective on shares of Veeva Systems from $281.00 to $307.00 and gave the stock a "buy" rating in a report on Monday, December 9th. JPMorgan Chase & Co. raised their target price on Veeva Systems from $208.00 to $218.00 and gave the company a "neutral" rating in a research note on Monday, December 16th. Finally, Canaccord Genuity Group boosted their price target on Veeva Systems from $210.00 to $270.00 and gave the stock a "hold" rating in a research note on Friday, December 6th. Two equities research analysts have rated the stock with a sell rating, eight have assigned a hold rating and sixteen have given a buy rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $255.28.
Check Out Our Latest Stock Report on VEEV
Veeva Systems Stock Down 3.0 %
Shares of NYSE:VEEV traded down $7.42 during trading on Monday, hitting $239.38. 2,104,746 shares of the company traded hands, compared to its average volume of 1,181,413. Veeva Systems Inc. has a one year low of $170.25 and a one year high of $258.93. The stock has a market capitalization of $38.86 billion, a price-to-earnings ratio of 59.11, a PEG ratio of 1.89 and a beta of 0.88. The business's fifty day moving average is $224.92 and its 200-day moving average is $220.34.
Veeva Systems Profile
(
Free Report)
Veeva Systems Inc provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and analytics solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States.
Recommended Stories
Before you consider Veeva Systems, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Veeva Systems wasn't on the list.
While Veeva Systems currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
